Ensysce Biosciences CEO Presents at Inaugural Clinical Pain Symposium in Amsterdam

Go back to Ensysce Biosciences CEO Presents at Inaugural Clinical Pain Symposium in Amsterdam
(NASDAQ: ENSC) Delayed: 0.44 +0.05 (12.82%)
Previous Close $0.39    52 Week High
Open $0.40    52 Week Low
Day High $0.45    P/E N/A 
Day Low $0.38    EPS
Volume 1,396,473